Inmune Bio Files 8-K on Security Holder Votes
Ticker: INMB · Form: 8-K · Filed: Jul 19, 2024 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | 8-K |
| Filed Date | Jul 19, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, voting
Related Tickers: INMB
TL;DR
INMB filed an 8-K for security holder votes - details TBD.
AI Summary
Inmune Bio, Inc. filed an 8-K on July 19, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the voting matters or outcomes, but it serves as an official notification to the SEC.
Why It Matters
This filing indicates that Inmune Bio, Inc. has held or is holding a meeting where security holders are voting on important company matters, which could impact corporate governance and future strategic decisions.
Risk Assessment
Risk Level: low — This filing is procedural and does not disclose new financial information or significant operational changes that would immediately impact the company's risk profile.
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- July 19, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- Boca Raton, Florida (location) — Principal Executive Offices
FAQ
What specific matters were submitted for a vote by Inmune Bio, Inc.'s security holders?
The filing states that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 19, 2024.
What is the principal executive office address for Inmune Bio, Inc.?
The principal executive office address for Inmune Bio, Inc. is 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432.
In which state is Inmune Bio, Inc. incorporated?
Inmune Bio, Inc. is incorporated in Nevada.
What is the Commission File Number for Inmune Bio, Inc.?
The Commission File Number for Inmune Bio, Inc. is 001-38793.
Filing Stats: 548 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-07-19 16:00:36
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per shares INMB The NASDAQ Stock Ma
Filing Documents
- ea0209501-8k_inmune.htm (8-K) — 28KB
- 0001213900-24-062986.txt ( ) — 199KB
- inmb-20240719.xsd (EX-101.SCH) — 3KB
- inmb-20240719_lab.xml (EX-101.LAB) — 33KB
- inmb-20240719_pre.xml (EX-101.PRE) — 22KB
- ea0209501-8k_inmune_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On July 19, 2024, INmune Bio Inc. (the "Company"), held its annual meeting of stockholders (the "Annual Meeting") . At the Annual Meeting, each share of the Company's common stock was entitled to one vote per share. The matters voted upon and the results are set forth below. Proposal One: Election of Directors. Stockholders elected each of the following nominees as directors to hold office until the next meeting of the Company's stockholders and until his or her successor is elected and qualified. A sixth director nominee, Edgardo Baracchini, resigned from the board of directors prior to the vote being finalized. Nominee Votes For Votes Withheld Broker Non-Votes Raymond J. Tesi, MD 9,947,830 516,892 4,069,201 J. Kelly Ganjei 9,627,979 836,743 4,069,201 Tim Schroeder 9,908,788 555,934 4,069,201 Scott Juda, JD 9,950,069 514,653 4,069,201 Marcia Allen 9,477,214 987,508 4,069,201 Proposal Two: Ratification of Appointment of Independent Auditor. Stockholders approved the ratification of the appointment of Marcum LLP as the Company's independent auditors for the fiscal year ending December 31, 2024. For Against Abstentions Broker Non-Votes 14,504,668 7,406 21,849 N/A 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INMUNE BIO INC. Date: July 19, 2024 By: /s/ David Moss David Moss Chief Financial Officer 2